Guilty as CHARGED: p53's expanding role in disease
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Unrestrained p53 activity during development, as occurs upon loss of the p53 negative regulators Mdm2 or Mdmx, causes early embryonic lethality. Surprisingly, co-expression of wild-type p53 and a transcriptionally-dead variant of p53, with mutations in both transactivation domains (p53(L25Q,W26S,F53Q,F54S)), also causes lethality, but later in gestation and in association with a host of very specific phenotypes reminiscent of a syndrome known as CHARGE. Molecular analyses revealed that wild-type p53 is inappropriately activated in p53(5,26,53,54/)(+) embryos, triggering cell-cycle arrest or apoptosis during development to cause CHARGE phenotypes. In addition, CHARGE syndrome is typically caused by mutations in the CHD7 chromatin remodeler, and we have shown that activated p53 contributes to phenotypes caused by CHD7-deficiency. Together, these studies provide new insight into CHARGE syndrome and expand our understanding of the role of p53 in diseases other than cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“strain, a C-terminal fragment of p53 is produced, provoking premature aging in p53m/C adults.(84) However, unlike the p5325,26,53,54/C embryos, there is no sign of increased basal p53 activity, and instead, stress signals are required to induce the p53 m protein to augment p53 stability and activity.”
BackgroundRescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 2×
“These observations provided the first demonstration that unrestrained p53 activity during development can drive embryonic lethality.(13,15,16) Similarly, Mdmx¡/¡ mice are Keywords: p53, transcriptional activation, CHARGE syndrome, CHD7, embryonic development, Ribosomopathy, Mdm2, neural Crest”
BackgroundSchwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106 · cited 1×
“p53 is a transcriptional activator, which binds to specific DNA elements throughout the genome, leading to the induction of p53 target genes involved in the apoptosis or cell-cycle arrest programs, although p53 can also act through transactivation-independent mechanisms such as direct induction of apoptosis through cy…”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“A direct role for p53 in triggering phenotypes upon telomere erosion is indicated by studies in telomerasedeficient mice, where germ cell depletion is partially rescued by p53 loss.(69) While telomere attrition clearly induces DNA damage, thereby activating p53, some effects may also be through ribosome biogenesis def…”
BackgroundModulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586 · cited 2×
“Another mouse strain, overexpressing a truncated, naturally-occurring isoform of p53 that lacks the first transactivation domain (D40), also exhibits growth retardation and premature aging.(85) However, expression of D40 does not affect wild-type p53 levels, and while some p53 target genes are hyperactivated, a subset…”
BackgroundDistinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Brady, C. A., Jiang, D., Mello, S. S., Johnson, T. M., Jarvis, L. A., Kozak, M. M., Broz, D. K., Basak, S., Park, E. J., McLaughlin, M. E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.035 · Cited by 533
Self-citation'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally
García‐Cao, I., García‐Cao, M., Martín‐Caballero, J., Criado, L. M., Klatt, P., Flores, J. M., Weill, J., Blasco, M. A., & Serrano, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf595 · Cited by 529
Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · cited 1×
“5), and this lethality is again fully rescued by p53 deficiency.(11,12,14) Subsequent studies using Mdm2 and Mdmx conditional mouse strains further revealed the necessity of regulating p53 in various tissues, including the heart, haematopoietic system, skin, bone, and neuroepithelium, where p53 activation causes incre…”
BackgroundThe p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Brady, C. A., & Attardi, L. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.064501 · Cited by 403
Self-citationPolo, S. E., Kaidi, A., Baskcomb, L., Galanty, Y., & Jackson, S. P. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.188 · Cited by 374 · cited 1×
“In addition, Chd4 regulates p53 at the post-translational level by deacetylating p53, such that Chd4 loss enhances p53 acetylation and activity.(56) In addition, embryos with duplication of 1p36, which contains the tumor suppressor gene Chd5, exhibit enhanced senescence and apoptosis as well as perinatal lethality, wh…”
BackgroundKeeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352 · cited 1×
“Subsequent studies using Mdm2 and Mdmx conditional mouse strains further revealed the necessity of regulating p53 in various tissues, including the heart, haematopoietic system, skin, bone, and neuroepithelium, where p53 activation causes increased cell-cycle arrest, senescence or apoptosis and perturbs proper tissue…”
BackgroundMigliorini, D., Denchi, E. L., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Helin, K., Pelicci, P. G., & Marine, J.-C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5527-5538.2002 · Cited by 313
mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation
Mendrysa, S. M., McElwee, M. K., Michalowski, J., O'Leary, K. A., Young, K. M., & Perry, M. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.462-473.2003 · Cited by 234
Tumor suppression and normal aging in mice with constitutively high p53 activity
Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210 · cited 1×
“In the Mdm2 hypomorphic mutant mice, in which one allele is null and the second allele has reduced Mdm2 expression due to the presence of a puromycin cassette in the Mdm2 locus, the ensuing phenotypes include lymphopenia, growth retardation, and radiosensitivity, associated with enhanced p53 transcriptional activity.(…”
BackgroundSingle-nucleotide polymorphisms in the p53 pathway regulate fertility in humans
Kang, H.-J., Feng, Z., Sun, Y., Atwal, G., Murphy, M. E., Rebbeck, T. R., Rosenwaks, Z., Levine, A. J., & Hu, W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904280106 · Cited by 193 · cited 1×
“Instead, mutations in p53 regulatory elements or in genes encoding key p53 regulators could have the effect of slightly activating p53 to promote CHARGE phenotypes and thus may be more likely to occur.(50) Collectively, our findings demonstrate a direct connection between Chd7 loss and p53 activation in CHARGE, highli…”
BackgroundSynergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
Xiong, S., Van Pelt, C. S., Elizondo-Fraire, A. C., Liu, G., & Lozano, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508500103 · Cited by 155
Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4
Grier, J. D., Xiong, S., Elizondo-Fraire, A. C., Parant, J. M., & Lozano, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.192-198.2006 · Cited by 149
Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development
Terzian, T., Wang, Y., Van Pelt, C. S., Box, N. F., Travis, E. L., & Lozano, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00555-06 · Cited by 116
CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome
Batsukh, T., Pieper, L., Koszucka, A. M., von Velsen, N., Hoyer-Fender, S., Elbracht, M., Bergman, J. E. H., Hoefsloot, L. H., & Pauli, S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq189 · Cited by 95 · cited 1×
“Notably, loss of Chd8, which interacts with Chd7, causes early embryonic lethality that is partially rescued by p53 deficiency.(55,58) Chd8 was found to bind to p53 along with H1 to suppress p53 transactivation activity, thereby preventing p53-mediated apoptosis during embryogenesis.”
BackgroundGannon, H. S., Donehower, L. A., Lyle, S., & Jones, S. N. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.02.007 · Cited by 87
Distinct roles of Mdm2 and Mdm4 in red cell production
Maetens, M., Doumont, G., Clercq, S. D., Francoz, S., Froment, P., Bellefroid, E., Klingmuller, U., Lozano, G., & Marine, J.-C. (2007) · Blood · doi:10.1182/blood-2006-03-013656 · Cited by 64
Cited by
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Mello, S. S., Valente, L. J., Raj, N., Seoane, J. A., Flowers, B. M., McClendon, J., Bieging-Rolett, K. T., Lee, J., Ivanochko, D., Kozak, M. M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.007 · Cited by 179
“Although hyperactive p53mutants have been described previously (reviewed in Van Nostrand and Attardi, 2014), the p5353,54 mutant is unique in displaying enhanced tumor suppressor capability.”
InfluentialSelf-citationMultifaceted role for p53 in pancreatic cancer suppression
Mello, S. S., Flowers, B. M., Mazur, P. K., Lee, J. J., Müller, F., Denny, S. K., Ferreira, S., Hanson, K., Kim, S. K., Greenleaf, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211937120 · Cited by 55
Self-citation
Metadata
- Authors
- Van Nostrand, J. L., & Attardi, L. D.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2014-12-15
- Volume
- 13
- Issue
- 24
- Pages
- 3798-3807
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2076489829
- Cited by
- 23
- References
- 24
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.